<https://invivoscribe.com/#/schema/logo/image/>
<http://schema.org/caption>
<https://invivoscribe.com/invivoscribe-submits-the-leukostrat-cdx-flt3-mutation-assay-to-support-daiichi-sankyo-submission-for-quizartinib-in-japan/>